Liver X receptors (LXRs) have anti-inflammatory properties. Whether LXRs play a role in posttranscriptional control of inflammatory cytokine expression is not clear. Here, we firstly identified that the synthetic LXR agonist T0901317 promoted IL-1β, IL-6 and TNFα mRNA degradation. Moreover, T0901317 destabilized TNFα mRNA through its 3′-untranslated region. In addition, T0901317 increased the expression of tristetraprolin (TTP), while antagonizing TTP with siRNA abrogated T0901317-mediated inflammatory cytokine mRNA decay. Interestingly, T0901317 repressed LPS-induced phosphorylation of ERK1/2 and p38 mitogen-activated protein kinase (MAPK) in THP-1 macrophages. The evidence presented here confirms that LXR activation with T0901317 inhibits the phosphorylation of ERK1/2 and p38 MAPK, likely resulting in the increased expression of TTP and the decay of LPS-induce inflammatory cytokine mRNAs.
Introduction
Inflammation is part of the complex stress response of host tissues to noxious stimulation, such as pathogens, damaged cells, and irritants [1, 2] . A moderate inflammation endows the body with a firstline of resistance to infection. However, inappropriately, prolonged or unchecked scaled inflammation can be harmful to the body and results in inflammatory diseases, autoimmune disorders, and cancers [3, 4] . Inflammatory cytokines are critical mediators of inflammation and host defense [5, 6] . Thus, the regulation of inflammatory cytokine production could potentially lead to new therapeutic strategies for inflammatory diseases.
The expression of inflammatory cytokines is accurately modulated in multiple processes, including gene transcription, mRNA translation, and mRNA degradation [7, 8] . Inflammatory cytokine mRNA degradation acts through cis-elements in the 3′-untranslated region (3′-UTR) of the mRNA, which mediates the recognition of a herd of RNA-binding proteins and affects mRNA stability [9] . One of the best studied cis-acting short sequences in the 3′-UTR of inflammatory cytokine mRNAs is the AU-rich element (ARE) [10, 11] . At present, multiple inflammatory cytokines have been found to undergo ARE-mediated decay, such as TNFα, IL-1β, IL-6, transforming growth factor-β, inducible nitric oxide synthase (iNOS), and IL-8 [5, 10] . Tristetraprolin (TTP) is a well-known RNA-binding protein, which recognizes and binds to AREs in the 3′-UTR of the mRNAs of multiple inflammatory cytokines and then promotes their degradation [12, 13] . Multiple signaling pathways have been involved in the regulation of TTP protein expression and stability. For example, its expression is controlled by mitogenactivated protein kinase (MAPK) family, and its anti-inflammatory activity is regulated by MAPK-mediated phosphorylation [14, 15] .
Liver X receptor α (LXRα) and LXRβ belong to the nuclear hormone receptor superfamily. Originally, they were shown to act as sterol sensors protecting the cells against cholesterol overload through stimulating reverse cholesterol transport (RCT) and activating its conversion to bile acids in the liver [16, 17] . In addition, LXRs also possess anti-inflammatory properties, because their activation reduces the expression of multiple proinflammatory cytokines, including TNF-α, COX-2, IL-1β, MMP-9 and iNOS [18] . We have previously shown that LXR agonist T0901317 could efficiently reduce the production of IL-1β, IL-6, and TNF-α in bronchoalveolar lavage of rats with acute lung injury [19] . The mechanism through which LXRs inhibit the transcription of proinflammatory genes may involve the suppression of proinflammatory transcription factors, including nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) [19] [20] [21] . However, whether LXRs play a role in post-transcriptional modulation of inflammatory cytokine mRNA expression is not clear.
ATP-binding cassette transporter A1 (ABCA1) has been known as a target gene of LXRs. LXR activation increases the expression of ABCA1 [22] . We have previously reported that ABCA1 is important for apolipoprotein A-I/TTP pathway-mediated post-transcriptional control of inflammatory cytokine mRNA decay [23] . Additionally, there is an abundance of evidence indicating that LXR agonist inhibits MAPK superfamily activation both in vitro and in vivo [24, 25] . In the light of these data, we hypothesized that LXR activation could promote TTP expression and TTP-mediated inflammatory cytokine mRNA decay. In this study, we examined the physiological function of LXRs in post-transcriptional modulation of inflammatory cytokine mRNA expression.
Materials and Methods

Materials
LPS (L4524, Escherichia coli 055:B5), Ponceau S stain and Trizol reagent were purchased from Sigma (St Louis, USA). Antibodies against TTP, ERK1/2, p38 MAPK, phospho-ERK1/2, phospho-p38 MAPK, and β-actin were purchased from Abcam (Cambridge, UK). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, USA). The First Strand cDNA Synthesis Kit (#k1622) was obtained from Fermentas (St Leon-Roth, Germany).
Cell culture
THP-1 cells (Cell Resource Center, IBMS, CAMS/PUMC, Beijing, China) were cultured at a density of 0.2-1.0 × 10 6 /ml in RPMI-1640 containing 0.1% non-essential amino acids, 100 U/ml penicillin, 100 μg/ml streptomycin, and 20% fetal bovine serum. Before their use in experiments, cells were pretreated with 160 nM phorbol-12-myristate-13-acetate to become fully differentiated macrophages.
mRNA decay assay mRNA decay was examined as described previously [26] . Briefly, THP-1 macrophages were treated with or without T0901317 for 6 h, and then exposed to LPS for 2 h. After LPS treatment, all of the cells were cultured with actinomycin D (ActD) to stop transcription. Total RNA from cells was extracted after ActD treatment at each time point (0, 30, 60, and 120 min). Inflammatory cytokine mRNAs were quantified using RT-PCR. Remnant inflammatory cytokine mRNAs in the percentage of the amount at time point 0 of ActD treatment were calculated.
TNFα 3′-UTR luciferase reporter assay
TNFα 3′-UTR luciferase reporter assay was conducted as described previously [27] . Briefly, a whole fragment of 3′-UTR TNFα mRNA (~799 kb) and a mutant form were cloned into pGL-3-Luc. THP-1 macrophages were seeded in 24-well plates and co-transfected with pGL-3-TNFα wild-type or mutant portion and pRL-TK, respectively, using Lipofectamine 2000 (Invitrogen, Carlsbad, USA). After 24 h of incubation, cells were treated with T0901317 for 6 h and then were lysed for luciferase reporter assays. For each experiment, luciferase values were expressed as a percentage of the luciferase expression without treatment.
Transfection with siRNA
The TTP siRNA and the scrambled siRNA which was used as a control were obtained from Biology Engineering Corporation (Shanghai, China). The sequences are as follows: TTP sense, 5′-UCGCCACCCCAAGUACAAATT-3′, and antisense, 5′-CUC UGCCACAAGUUCUACCTT-3′; scrambled siRNA sense, 5′-UGU GGAUGACUGAGUACCUGA-3′, and antisense, 5′-UCAGGUACU CAGUCAUCCACA-3′. THP-1 macrophages were transfected with the TTP siRNA or scrambled siRNA using Lipofectamine 2000 according to the manufacturer's instructions.
Real-time quantitative PCR
Total RNA was isolated by using Trizol reagent or the mirVana miRNA isolation kit (Ambion, Austin, USA) according to the manufacturer's instructions. Real-time quantitative PCR was performed with a Light Cycler Run 5.32 Real-Time PCR System (Roche, Basel, Switzerland). The relative expression of inflammatory cytokine mRNAs was calculated by using the 2 −ΔΔCt method. The primers are as follows: TNFα forward, 5′-CCACCACGCTCTTCTGTCTAC TG-3′, reverse, 5′-GGGCTACGGGCTTGTCACTC-3′; IL-6 forward, 5′-CTTCCAGCCAGTTGCCTTCTTG-3′, reverse, 5′-GGTC TGTTGTGGGTGGTATCCTC-3′; and IL-1β forward, 5′-TCGCTC AGGGTCACAAGAAA-3′, reverse, 5′-ATCAGAGGCAAGGA GGAAACAC-3′.
Western blot analysis
Protein was separated by 10% SDS-PAGE and transferred to the immobilon-P transfer membranes (Millipore, Bedford, USA). The membranes were blocked for 4 h in Tris buffered saline with Tween-20 (TBST), which contained 5% skimmed milk at room temperature, followed by incubation with antibodies against TTP, p-p38 MAPK, p-ERK1/2, and β-actin overnight at 4°C. Thereafter, the membranes were washed with TBST, incubated with HRP-conjugated goat antirabbit IgG polyclonal antibody for 50 min at room temperature, and then washed again with TBST. Immunoreactivity was detected by using ECL kit (Amersham, Piscataway, USA) according to the manufacturer's instructions. Analysis of target protein band intensity values was performed using the Labworks analysis software (Version 4; Ultra-Violet Products Ltd, Cambridge, UK).
Statistical analysis
Values were expressed as the mean ± SE. Statistical analysis was performed using SPSS 13.0 software. One-way ANOVA and Student's t-test were used to analyze the data within the intra group and inter group, respectively. Statistical significance was obtained when P < 0.05.
Results
LXR activation destabilizes LPS-induced inflammatory cytokine mRNAs
IL-1β, IL-6, and TNFα mRNA expressions after a time period of LPS stimulation were examined using real-time PCR. As shown in Fig. 1A -C, TNFα, IL-6, and IL-1β mRNAs underwent a significant increase, reaching a maximal at~2 h and then began to decline. Moreover, T0901317 pretreatment significantly decreased LPSinduced TNFα, IL-6, and IL-1β mRNAs at 2 h. To further examine whether the inhibition effect of LXR activation on proinflammatory cytokine expression was related to their mRNA decay, the role of T0901317 in the stability of LPS-induced inflammatory cytokine mRNAs was measured. THP-1 macrophages were pretreated with or without T0901317 for 6 h, and then stimulated with LPS for 2 h. Finally, ActD was used to suppress mRNA transcription and total RNA was extracted at 0, 30, 60, and 120 min after ActD treatment. As shown in Fig. 1D -F, T0901317 significantly decreased LPSinduced TNFα, IL-6, and IL-1β mRNA level at the 60 and 120 min after ActD treatment. These results imply that LXR activation could suppress inflammatory cytokine expression through promoting their mRNA destabilization.
LXR activation destabilizes TNFα mRNA through its 3′-UTR
Inflammatory cytokine mRNA degradation acts through ciselements in the 3′-UTR of the mRNA. TNFα is a central mediator of inflammation [28] . To determine whether LXR-induced TNFα mRNA decay is related to its 3′-UTR, luciferase reporter constructs were generated by cloning either the wild-type or a mutated portion of the full length human 3′-UTR of TNFα into the 3′-UTR of a pGL-3M-Luc vector ( Fig. 2A) . As expected, our results showed that pretreatment with T0901317 markedly inhibited the luciferase activity for the wild-type 3′-UTR of TNFα, but showed no repression effect for the mutated 3′-UTR of TNFα (Fig. 2B) . These results imply that LXR activation destabilizes TNFα mRNA through its 3′-UTR. Figure 1 . LXR activation destabilizes LPS-induced inflammatory cytokine mRNAs (A-C) THP-1 macrophages were stimulated with LPS (10 ng/ml) for the indicated time, and cytokine mRNAs were measured using qRT-PCR. (D-F) THP-1 macrophages were pretreated with T0901317 (10 μM) for 6 h, and then stimulated with LPS (10 ng/ml) for 2 h followed by treatment with ActD (5 μg/ml) to terminate the transcription. Cytokine mRNAs were measured using qRT-PCR at the indicated time points. Remnant cytokine mRNAs in percentage of the amount at the time point 0 of ActD treatment was shown. Data are expressed as the average of three independent experiments where each sample was tested in triplicate.
$ P < 0.05 versus LPS 0 h group, # P < 0.05 versus LPS 2 h group, and *P < 0.05 versus LPS group. . After 18 h, cells were stimulated with T0901317 (10 μM) for 6 h, and then stimulated with LPS (10 ng/ml) for 2 h, followed by treatment with ActD (5 μg/ml). Cytokine mRNAs were quantified using qRT-PCR at the indicated time points. Remnant cytokine mRNAs in percentage of the amount at the time point 0 of ActD treatment were calculated. Data are expressed as the average of three independent experiments where each sample was tested in triplicate. *P < 0.05 versus LPS group, # P < 0.05 versus LPS + T09 group. THP-1 macrophages were transiently transfected with pGL-3M-Luc vector carrying wild-type or a mutated portion of the TNFα 3′-UTR for 24 h and then stimulated with T0901317 (10 μM) for 6 h, following which luciferase reporter assays were performed. Data are expressed as the average of three independent experiments where each sample was tested in triplicate. *P < 0.05 versus Control group.
TTP is involved in LXR-mediated inflammatory cytokine mRNA decay TTP is a major ARE binding protein that regulates the stability of several inflammatory cytokine mRNAs [29] . To examine whether TTP plays a role in LXR-mediated inflammatory cytokine mRNA decay, the ability of T0901317 to modulate the expression of TTP was determined. As shown in Fig. 3A ,B, T0901317 significantly elevated the expression of TTP mRNA and protein both in LPS-free and LPS-stimulated THP-1 macrophages. To further verify that TTP was responsible for T0901317-induced inflammatory cytokine mRNA decay, a lost-of-function approach was applied. Treatment with TTP siRNA significantly inhibited the TTP protein expression (Fig. 3C) . T0901317 reduced LPS-induced TNFα, IL-6, and IL-1β mRNA levels (Fig. 3D-F) . However, TTP siRNA abrogated the destabilization of T0901317 on LPS-induced IL-1β, IL-6, and TNFα mRNAs in THP-1 macrophages. These results imply that LXRmediated inflammatory cytokine mRNA decay in LPS-stimulated THP-1 macrophages is mediated by TTP.
LXR activation inhibits ERK/p38 signaling pathway
In some cell types, LXR activation inhibits ERK1/2 and p38 MAPK signaling pathways [24, 25] . To verify whether LXR activation also inhibits these two signaling pathways in LPS-stimulated THP-1 macrophages, western blot analysis was carried out for phosho-ERK1/2 and phosho-p38 MAPK. As shown in Fig. 4 , resting THP-1 macrophages exhibited basal phosphorylation of ERK1/2 and p38 MAPK. LPS stimulation resulted in a rapid increase in phosphorylation of these two pathways. However, LPS-induced phosphorylation of ERK1/2 and p38 MAPK was markedly suppressed by T0901317. These results imply that LXR activation inhibits LPSinduced phosphorylation of ERK1/2 and p38 MAPK in THP-1 macrophages.
Discussion
In this study, we firstly demonstrated that LXR agonist T0901317 promoted inflammatory cytokine mRNA degradation. Moreover, T0901317 destabilized TNFα mRNA through its 3′-UTR. In addition, T0901317 increased the expression of TTP, while antagonizing of TTP with siRNA abrogated T0901317-mediated inflammatory cytokine mRNA decay in LPS-stimulated THP-1 macrophages. Interestingly, T0901317 inhibited LPS-induced phosphorylation of ERK1/2 and p38 MAPK in THP-1 macrophages. The results presented here confirm that LXRs play a vital role in post-transcriptional modification of inflammatory cytokine mRNAs and therapeutic interventions by targeting LXR activity may open new avenues for controlling inflammatory diseases. In macrophages, previous studies have shown that LXR agonists reduce the expressions of multiple proinflammatory cytokines, including TNFα, COX-2, IL-1β, MMP-9, and iNOS [18, 19] . The mechanism through which LXR activation inhibits the transcription of proinflammatory genes may involve the suppression of proinflammatory transcription factors, such as NF-κB and AP-1 [19, 20] . Apart from their transcriptional suppression, LXR agonists can directly increase the expression of arginase II gene, which contains a classical LXRE sequence in its regulatory region. Arginase II interferes with iNOS by depleting their common substrate, L-arginine [30] . Here, our results showed that LXR activation by T0901317 promoted inflammatory cytokine mRNA degradation, and such action might be mediated by their 3′-UTRs. Combining the previous findings and our findings in this study, we believe that LXRs can suppress proinflammatory cytokine expression at both transcriptional and posttranscriptional levels. However, at present it is still unclear which mechanism is predominant. Further work is needed for a better understanding of the anti-inflammatory mechanism of LXRs.
The post-transcriptional control of cytokine expression is exerted by trans-acting RNA-binding proteins and cis-acting sequence Figure 4 . LXR activation inhibits LPS-induced phosphorylation of ERK1/2 and p38 MAPK signaling pathways THP-1 macrophages were pretreated with T0901317 (10 μM) for 6 h, and then stimulated with or without LPS (10 ng/ml) for 2 h. p-ERK1/2 and p-p38 MAPK protein were analyzed by western blot analysis. Representative blot (A) and fold changes in densitometry measurements (B) of three experiments are shown. *P < 0.05 versus LPS group, # P < 0.05 versus LPS (−) + T09(−) group. elements, largely in the 3′-UTR. TTP is one of the proverbial destabilizing RNA-binding proteins for its mRNA-destabilizing activity [29] . Here, we firstly identified that LXR activation increased the expression of TTP. Moreover, TTP siRNA abrogated LXRmediated inflammatory cytokine mRNA decay in LPS-stimulated THP-1 macrophages. These data reveal that TTP is implicated in LXR-mediated inflammatory cytokine mRNA decay. The family of RNA-binding proteins consists of numerous members. Most of them are abundant in mammalian cells. Therefore, whether other members are also involved in LXR-mediated inflammatory cytokine mRNA decay remain to be investigated in the future.
It is well established that both the ERK1/2 and p38 MAPK pathways are required to regulate the TTP expression and function. A previous study in RAW264.7 cells showed that combined activation of the ERK and p38 pathways inhibits TNFα message decay, by specifically inhibiting TTP function [31] . When we further explored the role of T0901317 in the ERK1/2 and p38 MAPK pathways, it was found that T0901317 suppressed LPS-induced phosphorylation of ERK1/2 and p38 MAPK in THP-1 macrophages. These results reveal that the increased expression of TTP induced by LXR activation, at least partially, is mediated by deactivation of the ERK1/2 and p38 MAPK pathways.
In summary, our results confirm that LXR activation inhibits the phosphorylation of ERK1/2 and p38 MAPK, likely resulting in increased expression of TTP and the decay of LPS-induce inflammatory cytokine mRNAs. These results could lead to the identification of potential new anti-inflammatory mechanism for LXRs. Given the importance of LXRs in inflammatory regulation, these findings may have translational implications.
